Carlos Garces
Overview
Explore the profile of Carlos Garces including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutierrez-Tobar I, Carvajal C, Vasquez-Hoyos P, Diaz-Diaz A, Londono Ruiz J, Andrade J, et al.
Front Pediatr
. 2024 Jun;
12:1386310.
PMID: 38895192
Background: infections are a significant cause of morbidity and mortality in pediatric populations worldwide. The Staphylo Research Network conducted an extensive study on pediatric patients across Colombia from 2018 to...
2.
Nino-Serna L, Mesa Muftoz C, Copete D, Trujillo M, Restrepo A, Garces C
Andes Pediatr
. 2023 Nov;
94(3):325-332.
PMID: 37909935
Objective: To describe the clinical characteristics of pediatric patients using therapeutic and prophylactic lock therapy for six years in a high-complexity hospital in Colombia. Patients And Method: Cross-sectional descriptive study...
3.
Torres-Martinez C, Chaparro E, Marino A, Falleiros-Arlant L, Camacho-Moreno G, Castillo M, et al.
Rev Panam Salud Publica
. 2023 Feb;
47:e24.
PMID: 36726600
The objective of this article was to consider the vaccination challenges in Colombia and Peru and the role of pediatric combination vaccines in overcoming these challenges. Barriers to including new...
4.
Santolaya M, Contardo V, Torres J, Lopez-Medina E, Rosanova M, Alvarez A, et al.
Rev Chilena Infectol
. 2022 May;
38(6):857-909.
PMID: 35506861
The Committee for Infections in Immunocompromised Children of Sociedad Latinoamericana de Infectología Pediátrica, presents this Consensus document, titled "Management of episodes of febrile neutropenia in children with cancer. Consensus of...
5.
Rueda Z, Aguilar Y, Maya M, Lopez L, Restrepo A, Garces C, et al.
BMC Pediatr
. 2022 Apr;
22(1):169.
PMID: 35361166
Background: Pneumonia is the leading cause of mortality in pediatric population. The etiology of pneumonia in this population is variable and changes according to age and disease severity and where...
6.
Roya-Pabon C, Restrepo A, Morales O, Arango C, Maya M, Bermudez M, et al.
Pediatr Rep
. 2022 Feb;
14(1):71-80.
PMID: 35225880
Tuberculosis (TB) in the pediatric population is a major challenge. Our objective was to describe the clinical and microbiological characteristics, radiological patterns, and treatment outcomes of children and adolescents (from...
7.
Rueda Z, Bermudez M, Restrepo A, Garces C, Morales O, Roya-Pabon C, et al.
Int J Infect Dis
. 2022 Jan;
116:348-354.
PMID: 35063681
Objectives: This study aimed to evaluate the utility of induced sputum (IS) for the diagnosis of community-acquired pneumonia (CAP) in pediatric population. Methods: This cross-sectional study included pediatric population aged...
8.
Pena M, Ampuero M, Garces C, Gaggero A, Garcia P, Velasquez M, et al.
Int J Infect Dis
. 2021 May;
107:201-204.
PMID: 33945868
Screening, testing and contact tracing plays a pivotal role in control of the COVID-19 pandemic. To enable this it is necessary to increase the testing capacity. This study compared a...
9.
Saenz-Jalon M, Sarabia-Cobo C, Roscales Bartolome E, Santiago Fernandez M, Velez B, Escudero M, et al.
J Trauma Nurs
. 2020 May;
27(3):146-150.
PMID: 32371731
Pin-site infections remain a common clinical complication in patients with external fixators. Pin-site care is commonly performed with either chlorhexidine-alcohol solution or povidone-iodine solution. This study aimed to investigate the...
10.
Arango-Franco C, Moncada-Velez M, Beltran C, Berrio I, Mogollon C, Restrepo A, et al.
J Clin Immunol
. 2018 Sep;
38(7):794-803.
PMID: 30264381
Purpose: CARD9 deficiency is an inborn error of immunity that predisposes otherwise healthy humans to mucocutaneous and invasive fungal infections, mostly caused by Candida, but also by dermatophytes, Aspergillus, and...